PropertyValue
?:abstract
  • The article highlights an up-to-date progress in studies of structure and the remedial aspects of novel coronavirus 2019-nCoV, renamed as SARS-CoV-2, leading to the disease COVID-19, a pandemic. In general, all CoVs including SARSCoV-2 are spherical positive single-stranded RNA viruses containing spike (S) protein, envelope (E) protein, nucleocapsid (N) protein, and membrane (M) protein, where S protein has a receptor-binding domain (RBD) that mediates the binding to host cell receptor, angiotensin converting enzyme 2 (ACE2). The article details the repurposing of some drugs to be tried for COVID-19 and presents the status of vaccine development so far. Besides drugs and vaccines, the role of convalescent plasma (CP) therapy to treat COVID-19 is also discussed.
?:creator
?:doi
  • 10.2174/1568026620666200922112300
?:doi
?:journal
  • Current_topics_in_medicinal_chemistry
?:license
  • unk
?:pmid
?:pmid
  • 32962613.0
?:publication_isRelatedTo_Disease
?:source
  • Medline
?:title
  • Progress in Studies on Structural and Remedial Aspects of Newly Born Coronavirus, SARS-CoV-2.
?:type
?:year
  • 2020-09-22

Metadata

Anon_0  
expand all